Related Experiment Video

Updated: May 27, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

The role of microRNAs in human liver cancers

Chiara Braconi1, Jon C Henry, Takayuki Kogure

  • 1The Ohio State University, Columbus, OH, USA.

Seminars in Oncology
|November 16, 2011
PubMed

Insights

MicroRNAs (miRNAs) are crucial in understanding hepatocellular carcinoma (HCC) development. Research highlights their role in HCC pathogenesis, as biomarkers, and potential therapeutic targets.

Area of Science:

  • Hepatocellular carcinoma (HCC) research
  • Molecular biology
  • Biomarker discovery

Background:

  • Hepatocellular carcinoma (HCC) is a significant global liver cancer.
  • MicroRNAs (miRNAs) are increasingly recognized for their role in HCC pathogenesis.
  • Understanding miRNA involvement is key to advancing HCC treatment and diagnosis.

Purpose of the Study:

  • To review current research on miRNA expression in human HCC.
  • To discuss the role of specific miRNAs in HCC pathogenesis.
  • To explore the potential of miRNAs as biomarkers and therapeutic targets for HCC.

Main Methods:

  • Literature review of studies on miRNA expression in human HCC.
  • Analysis of recent findings on miRNA involvement in HCC.
  • Synthesis of information on miRNA-based biomarkers and therapeutics.

Main Results:

  • miRNA expression patterns are altered in human HCC.
  • Specific miRNAs are implicated in the development and progression of HCC.
  • miRNAs show promise as diagnostic and prognostic biomarkers.
  • Targeting miRNAs is a developing therapeutic strategy for HCC.

Conclusions:

  • miRNAs play a critical role in hepatocellular carcinoma.
  • Further research into miRNA function and application is warranted.
  • miRNAs represent a promising avenue for HCC biomarker and therapeutic development.

More Related Videos

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

Published on: October 26, 2017

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...